Abstract
Background
Two significant limitations of intraperitoneal drug therapy are limited drug distribution and poor penetration into peritoneal nodules. A possible solution is the application of the so-called “therapeutic pneumoperitoneum,” taking advantage of the gaseous nature and the pressure of capnoperitoneum during laparoscopy. Our objective was to develop a device able to apply such therapeutic pneumoperitoneum.
Methods
The technology presented here is a spraying device and can be introduced through a trocar. It is driven by mechanical pressure and consists of an injector, a line, and a nozzle. An in vivo experimental study was performed in five pigs. A transvaginal cholecystectomy was performed. At the end of the procedure, a standard dose of methylene blue was sprayed/infused into the abdominal cavity for 30 min (4 test animals w/therapeutic pneumoperitoneum (12 mmHg CO2) and 1 control animal w/conventional lavage (2 l intra-abdominal volume with extracorporeal circulation)). At the end of the procedure, all animals were autopsied and the peritoneum was analyzed. Outcome criteria were: (1) drug distribution (as assessed by the stained peritoneal surface at autopsy), and (2) diffusion into the peritoneum (presence or not of macroscopic staining of the outer aspect of the peritoneum immediately after surgery).
Results
Stained peritoneal surface was larger after aerosol application compared with peritoneal lavage, and staining more intense. Hidden peritoneal surfaces and the anterior abdominal wall were stained only in the aerosol group. In contrast to peritoneal lavage, the outer aspect of peritoneal membrane was immediately stained after pressurized spraying.
Conclusions
This device and the related approach significantly improve both distribution and penetration of a test substance into the peritoneal cavity in a large animal model. This might be a significant progress in treating intraperitoneal disease, in particular peritoneal carcinomatosis.
Similar content being viewed by others
References
Markman M (1985) Intracavitary chemotherapy [review]. Crit Rev Oncol Hematol 3:205–233
Sugarbaker PH, Gianola FJ, Speyer JL, Wesley R, Barofsky I, Myers CE (1985) Prospective randomized trial of intravenous v. intraperitoneal 5-FU in patients with advanced primary colon or rectal cancer. Semin Oncol 12:101–111
Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221:29–42
Elias D, Lefevre JH, Chevalier J, Brouquet A, Marchal F, Classe JM, Ferron G, Guilloit JM, Meeus P, Goéré D, Bonastre J (2009) Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 27:681–685
Alberts DS, Liu PY, Hannigan EV, O’Toole R, Williams SD, Young JA, Franklin EW, Clarke-Pearson DL, Malviya VK, DuBeshter B (1996) Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Engl J Med 335:1950–1955
Maggiori L, Elias D (2010) Curative treatment of colorectal peritoneal carcinomatosis: current status and future trends [review]. Eur J Surg Oncol 36:599–603
Markman M (2003) Intraperitoneal antineoplastic drug delivery: rationale and results. Lancet Oncol 4:277–283
Dedrick RL, Flessner MF (1997) Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure. J Natl Cancer Inst 89:480–487
Reymond MA, Hu B, Garcia A, Reck T, Kockerling F, Hess J, Morel P (2000) Feasibility of therapeutic pneumoperitoneum in a large animal model using a microvaporisator. Surg Endosc 14:51–55
Alkhamesi NA, Ridgway PF, Ramwell A, McCullough PW, Peck DH, Darzi AW (2009) Peritoneal nebulizer. A novel technique for delivering intraperitoneal therapeutics in laparoscopic surgery to prevent locoregional recurrence. Surg Endosc 19:1142–1146
Sharon A, Hirsh I, Kaufman Y, Ostrovski L, Brandes-Klein O, Spiegel D, Shenderey A, Lissak A (2008) The effect of continuous intraabdominal nebulization of lidocaine during gynecological laparoscopic procedures: a pilot study. Gynecol Surg 5:221–225
Druckrey-Fiskaaen KT, Janssen MW, Omidi L, Polze N, Kaisers U, Nur I, Goldberg E, Bokel G, Hauss J, Schön MR (2007) Laparoscopic spray application of fibrin sealant effects on hemodynamics and spray efficiency at various application pressures and distances. Surg Endosc 21:1750–1759
Greib N, Schlotterbeck H, Dow WA, Joshi GP, Geny B, Diemunsch PA (2008) An evaluation of gas humidifying devices as a means of intraperitoneal local anesthetic administration for laparoscopic surgery. Anesth Analg 107:549–551
Canis M, Matsuzaki S, Bourdel N, Jardon K, Cotte B, Botchorishvili R, Rabischong B, Mage G (2007) Peritoneum and laparoscopic environment [review]. Bull Cancer 94:1043–1051
Flessner MF (1996) Small-solute transport across specific peritoneal tissue surfaces in the rat. J Am Soc Nephrol 7:225–233
Steller MA, Egorin MJ, Trimble EL, Bartlett DL, Zuhowski EG, Alexander HR, Dedrick RL (1999) A pilot phase I trial of continuous hyperthermic peritoneal perfusion with high-dose carboplatin as primary treatment of patients with small-volume residual ovarian cancer. Cancer Chemother Pharmacol 43:106–114
Elias D, Goéré D (2007) Treat the peritoneum with respect! It’s our first line of defense against carcinomatosis. J Chir (Paris) 144:275–276
Los G, Mutsaers PH, van der Vijgh WJ, Baldew GS, de Graaf PW, McVie JG (1989) Direct diffusion of cis-diaminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy. Cancer Res 49:3380–3384
Los G, Mutsaers PH, Lenglet WJ, Baldew GS, McVie JG (1990) Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment. Cancer Chemother Pharmacol 25:389–394
Betton D, Greib N, Schlotterbeck H, Joshi GP, Ubeaud-Sequier G, Diemunsch P (2010) The pharmacokinetics of ropivacaine after intraperitoneal administration: instillation versus nebulization. Anesth Analg 111:1140–1145
Disclosures
This study was funded by Reger Medizintechnik GmbH, Rottweil, Germany. Alexander Hetzel is employed by and has an equity interest in Reger Medizintechnik. Wiebke Solaß, Giorgi Nadiradze, Emil Sagynaliev, and Marc A. Reymond have no conflicts of interest or financial ties to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Solaß, W., Hetzel, A., Nadiradze, G. et al. Description of a novel approach for intraperitoneal drug delivery and the related device. Surg Endosc 26, 1849–1855 (2012). https://doi.org/10.1007/s00464-012-2148-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-012-2148-0